Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-01 · accession 0001562180-22-001077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-01-31 | SNDX | Nolte Alexander | CAO | J - Other | $12.39 | +968 | 968 | New | +$12.0K |
| D | 2022-02-03 | 2022-02-01 | SNDX | Nolte Alexander | CAO | S - Sale | $16.65 | -968 | 0 | -100% | -$16.1K |
| D | 2022-02-03 | 2022-02-02 | SNDX | Nolte Alexander | CAO | A - Grant | $15.79 | +30.0K | 30.0K | New | +$473.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | J | A | 968 | $12.39 | 968 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-01 | S | D | 968 | $16.65 | 0 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2022-02-02 | A | A | 30,000 | $15.79 | 30,000 | D | $15.79 · — to 2032-02-02 | 30,000 Common Stock | (F2) 1/48th of the shares subject to the option shall vest monthly over a four-year period. |